AHK-Cu: the hair-research copper peptide with one study behind it

The short version: AHK-Cu is a tripeptide bound to copper, one letter away from the much better studied GHK-Cu. Its reputation as a hair peptide rests on a single 2007 paper, in which human hair follicles and papilla cells responded to it in the lab. Nobody has published an animal study or a human trial since. Even GHK, the famous cousin, has no human hair trial using the copper form that we could find.
One letter, and a link to your blood
We covered the basics of copper peptides, and the single-letter swap between GHK and AHK, in our GHK-Cu vs AHK-Cu explainer. This piece goes further into the evidence, so here is just one extra bit of chemistry first.
Blood plasma carries two well-known natural copper grabbers. One is GHK itself. The other is the front end of human albumin, a major blood protein, whose first four amino acids are D-A-H-K. Researchers have studied that short stretch as a tight copper-binding site in its own right. AHK matches the last three letters of albumin’s site, which makes it look like a relative of both.
It isn’t a copy of either, though. In albumin’s site the histidine sits third in line, and a 2011 structural study found copper held there by four nitrogen contacts. In GHK, the histidine is second and copper is held by three. AHK keeps its histidine second, like GHK. We found no published structure for AHK-Cu itself, so how it holds copper hasn’t been measured directly.
The one study, in detail
Pyo and colleagues, dermatologists at Seoul National University, published it in Archives of Pharmacal Research in 2007. They used two lab models.
The first was whole human hair follicles, kept alive in culture outside the body. The second was dermal papilla cells. They form a small cluster sitting at the bottom of every follicle, acting as its control centre, and the team grew them on their own in dishes.
With AHK-Cu added at extremely low concentrations, the follicles grew longer and the papilla cells multiplied. The team then looked at programmed cell death. Proteins that protect cells (Bcl-2, relative to Bax) went up, and the cut-down forms of caspase-3 and PARP, two signs of a cell dismantling itself, went down. But when they counted dying cells directly with a staining test, the drop wasn’t statistically significant.
Their conclusion was a proposal, worded carefully: AHK-Cu may encourage follicles to grow by pushing papilla cells to multiply and keeping them from dying off. That’s a hypothesis from tissue in a dish, and we found no published follow-up.
See our lab reports before you order →
Side by side with GHK-Cu
A 2026 review of short peptides for hair loss, in Biomedicines, sorted each peptide by the strongest kind of evidence behind it. It’s a handy way to see the gap.
| Level of evidence | AHK-Cu | GHK-Cu |
|---|---|---|
| Lab work | Papilla cells and hair follicles in culture (one 2007 paper) | Decades of work, going back to its discovery in 1973 |
| Animal studies | None found | Wound healing studied in rats, mice, pigs and dogs |
| Human skin studies | None found | Placebo-controlled cream studies in women, mostly 12 weeks |
| Human hair trial | None found | One trial, but with GHK bound to 5-ALA, not copper |
| 2026 review’s rating for hair | Experimental evidence | Clinical evidence |
The review adds that AHK-Cu’s signalling mechanism is less well characterised than GHK-Cu’s. It also points out a habit across the whole field: most hair peptide studies never explained how they chose the amounts they tested.
The GHK hair trial isn’t quite what it seems
That “clinical evidence” for GHK deserves a closer look. The trial behind it, published in Annals of Dermatology in 2016, gave 45 men with pattern hair loss one of two strengths of a product called ALAVAX, or a placebo, for six months.
ALAVAX is GHK joined to 5-aminolevulinic acid (5-ALA). There’s no copper in it. Hair counts went up more in both active groups than on placebo, and the weaker strength showed the bigger average rise. The comparison the authors reported as significant against placebo was for that weaker strength. Hair length and thickness didn’t differ between the groups.
So the one human hair trial in this family tested a different complex altogether. For GHK-Cu, the copper form, the human data is about skin creams. For AHK-Cu, there’s no human data of any kind.
If you remember one thing: AHK-Cu’s entire record is one 2007 study of follicles and cells in a dish, and even its better-known cousin has never been tested on hair in people in its copper form.
Where the evidence stops
- One lab, one paper. We found no independent repeat of the 2007 results.
- No animal work and no human work. A search of ClinicalTrials.gov turned up no registered trial for AHK-Cu.
- The cousin’s data doesn’t transfer. Swap a single amino acid and both copper binding and cell responses can shift. GHK-Cu results say nothing direct about AHK-Cu.
- A dish is not a scalp. A follicle in culture has no blood supply and none of the body’s wider signalling around it.
- Not a medicine anywhere. We found no approval for AHK-Cu, for any use, in any country.
A note on framing
The 2007 results came from a university lab working with human tissue under controlled conditions. They describe how cells behaved in a dish, not what happens on a head. We sell to researchers, and we’d rather you knew the record is this thin before you read a single product claim about it, including on a vial.
Where JP fits
JP Research supplies AHK-Cu as research-grade lyophilised powder in a 50mg vial, for laboratory research use only, alongside GHK-Cu. We don’t hold an independent lab report for AHK-Cu yet, and the product page says so. Our reconstitution and storage guide covers handling, and our guide to reading a COA explains what to check on a lab report.
Looking for copper peptide skincare rather than research material? JP Beauty, our skincare line, makes a ready-made GHK-Cu Serum for skin.
Browse the skin research range →
Sources
- Pyo et al.: The effect of tripeptide-copper complex on human hair growth in vitro (Archives of Pharmacal Research, 2007)
- Overview of short peptides for hair loss (Biomedicines, 2026)
- Lee et al.: Efficacy of a complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide on hair growth (Annals of Dermatology, 2016)
- Pickart et al.: GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration (BioMed Research International, 2015)
- Hureau et al.: X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes (Chemistry, 2011)
- Bar-Or et al.: An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species (BBRC, 2001)
All JP Research products are supplied strictly for in-vitro research and laboratory use only. They are not intended for human or animal consumption, medical treatment, or diagnostic use. Nothing in this article constitutes medical advice.